Opportunity Information: Apply for RFA FD 15 025
Apply for RFA FD 15 025
- The Food Drug Administration in the food and nutrition health sector is offering a public funding opportunity titled "FDA Drug Residue Cooperative Agreement Program (U18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103 Food and Drug AdministrationResearch.
- This funding opportunity was created on Jun 22, 2015 and posted on May 8, 2015.
- Applicants must submit their applications by Jul 24, 2015 The application deadline has been revised. The current application deadline is July 15, 2015 The new application deadline is July 24, 2015, by 1159 PM Eastern Time See Notice of Change NOT FD 15 070. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $800,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $125,000.00 in funding.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: State governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FDA Drug Residue Cooperative Agreement Program (U18), announced under Funding Opportunity Number RFA-FD-15-025, was a discretionary federal funding opportunity from the U.S. Food and Drug Administration focused on strengthening state-level efforts to prevent illegal drug residues in foods derived from animals. The core purpose of the program was public health protection: helping states build or improve practical, prevention-oriented systems that reduce the chance that consumers are exposed to unsafe or unlawful residues in edible products from food animals. Rather than concentrating on enforcement alone, the opportunity emphasized prevention through education, outreach, training, and the promotion of effective management practices around proper drug use in animals.
A major theme of the announcement is capacity-building for existing state tissue residue and drug residue prevention programs, especially in states where these programs needed a stronger foundation. FDA intended the cooperative agreements to support states in developing clearer, more effective ways to communicate best practices to producers, veterinarians, and others involved in raising and marketing food animals. The funding was meant to increase knowledge of correct drug use (including appropriate administration and withdrawal times) and to support related prevention activities that can reduce the occurrence of illegal residues before they ever reach the food supply. In practice, this includes improving educational outreach strategies, refining training programs, and strengthening how states promote residue-prevention management practices in the field.
Another key outcome described in the opportunity is program improvement through measurement and evaluation. The cooperative agreement structure signals that FDA expected active collaboration with awardees, and the announcement explicitly notes activities such as measuring the performance of existing state drug residue prevention programs, identifying gaps or areas for improvement, and, where needed, developing new or upgraded program elements. The intent was to help state agencies better target their resources and direction so that their programs more consistently reduce illegal drug residue outcomes in animal-derived foods.
In terms of funding mechanics and eligibility, the program anticipated making about seven awards with an estimated total funding amount of $800,000. Individual awards were expected to range widely, with an award ceiling of $125,000 and an award floor of $1,000. There was no cost-sharing or matching requirement listed. Eligibility was limited to state governments, reflecting the program’s goal of reinforcing state-run prevention infrastructure and aligning state activities with broader federal food safety objectives. The activity category was listed under Food and Nutrition and Health, and the relevant CFDA listing was 93.103 (Food and Drug Administration Research).
Timeline details indicate the opportunity was posted May 8, 2015, with a revised application deadline. While the original closing date was July 15, 2015, the deadline was extended to July 24, 2015, by 11:59 PM Eastern Time, with the change referenced in Notice of Change NOT-FD-15-070. The opportunity was later archived on August 14, 2015. For applicants needing access assistance or administrative support, the listed FDA grants management contact was Daniel Lukash, Grants Management Specialist (240-402-7596, daniel.lukash@fda.hhs.gov), and the full announcement was available through the NIH Guide for Grants and Contracts link referenced in the notice.
Overall, this grant opportunity was designed to help states move from reactive responses to residue violations toward stronger, better-measured prevention programs, using training, outreach, communication, and performance assessment to reduce illegal drug residues in the human food supply originating from food animals.
FDA Drug Residue Cooperative Agreement Program (U18) (RFA-FD-15-025) - FAQs
What was the FDA Drug Residue Cooperative Agreement Program (U18)?
The FDA Drug Residue Cooperative Agreement Program (U18) was a discretionary federal funding opportunity from the U.S. Food and Drug Administration aimed at strengthening state-level efforts to prevent illegal drug residues in foods derived from animals.
What was the main goal of this program?
The core goal was public health protection by helping states build or improve practical, prevention-oriented systems that reduce the likelihood that consumers are exposed to unsafe or unlawful drug residues in edible products from food animals.
Was the program focused on enforcement actions?
No. While residue issues can involve enforcement, the opportunity emphasized prevention rather than enforcement alone, prioritizing education, outreach, training, and promotion of effective management practices related to proper drug use in animals.
What kinds of activities were emphasized as prevention strategies?
The announcement emphasized prevention strategies such as education and outreach, training efforts, improved communication of best practices, and promotion of effective management practices around correct drug use in animals, including appropriate administration and withdrawal times.
Who was the intended audience for the outreach and communication efforts?
The opportunity highlighted improving communication of best practices to producers, veterinarians, and others involved in raising and marketing food animals.
What did "capacity-building" mean in this opportunity?
Capacity-building referred to supporting existing state tissue residue and drug residue prevention programs, especially where those programs needed a stronger foundation, by improving systems, training, outreach strategies, and program elements that prevent illegal residues.
What outcomes was FDA trying to achieve for state programs?
The opportunity described outcomes such as stronger prevention infrastructure, improved educational outreach and training, better promotion of residue-prevention management practices, and more consistent reduction of illegal drug residue outcomes in animal-derived foods.
Did the program include measurement and evaluation requirements or expectations?
Yes. A key outcome described was program improvement through measurement and evaluation, including measuring performance of existing state drug residue prevention programs, identifying gaps or areas for improvement, and developing new or upgraded program elements when needed.
Why was this offered as a cooperative agreement rather than another type of award?
The cooperative agreement structure signaled that FDA expected active collaboration with awardees, and the announcement referenced activities tied to performance measurement, gap identification, and program improvement efforts.
How many awards were anticipated?
The program anticipated making about seven awards.
What was the estimated total funding amount for all awards?
The estimated total funding amount across the program was $800,000.
What was the expected funding range for individual awards?
Individual awards were expected to range widely, with an award ceiling of $125,000 and an award floor of $1,000.
Was there a cost-sharing or matching requirement?
No cost-sharing or matching requirement was listed for this opportunity.
Who was eligible to apply?
Eligibility was limited to state governments, reflecting the program's goal of reinforcing state-run prevention infrastructure and aligning state activities with broader federal food safety objectives.
What was the Funding Opportunity Number for this program?
The Funding Opportunity Number (FON) was RFA-FD-15-025.
What was the CFDA listing associated with this opportunity?
The relevant CFDA listing was 93.103 (Food and Drug Administration Research).
What activity category was this program listed under?
The activity category was listed under Food and Nutrition and Health.
When was the opportunity posted?
The opportunity was posted on May 8, 2015.
What was the application deadline?
The application deadline was revised. The original closing date was July 15, 2015, and it was extended to July 24, 2015, by 11:59 PM Eastern Time.
What notice documented the deadline extension?
The deadline extension was referenced in Notice of Change NOT-FD-15-070.
Was this opportunity eventually archived?
Yes. The opportunity was later archived on August 14, 2015.
Who was the FDA grants management contact listed for administrative or access assistance?
The listed FDA grants management contact was Daniel Lukash, Grants Management Specialist.
What contact details were provided for the grants management specialist?
The contact details provided were: 240-402-7596 and daniel.lukash@fda.hhs.gov.
Where could applicants find the full announcement?
The full announcement was available through the NIH Guide for Grants and Contracts link referenced in the notice.
What was the broader public health problem this program aimed to address?
The program aimed to reduce the chance that consumers are exposed to unsafe or unlawful drug residues in edible products from food animals by strengthening prevention systems at the state level.
How did FDA describe the shift in approach it wanted states to make?
The opportunity was designed to help states move from reactive responses to residue violations toward stronger, better-measured prevention programs grounded in training, outreach, communication, and performance assessment.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: National Park Service Collaborative Restoration Projects with Southwest EPMT
Previous opportunity: Responsible Fatherhood Opportunities for Reentry and Mobility
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA FD 15 025
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA FD 15 025) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Apply for RFA FD 15 018 Funding Number: RFA FD 15 018 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $70,000 |
| Implementation of the Animal Feed Regulatory Program Standards (AFRPS) (U18) Apply for RFA FD 15 021 Funding Number: RFA FD 15 021 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $750,000 |
| Food Protection Rapid Response Team (RRT) (U18) Apply for RFA FD 15 020 Funding Number: RFA FD 15 020 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $450,000 |
| Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases (R01) Apply for RFA DK 15 017 Funding Number: RFA DK 15 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $450,000 |
| NIDDK Centers for Diabetes Translation Research (P30) Apply for RFA DK 15 003 Funding Number: RFA DK 15 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding Course Offerings for State and Local Regulators in the Integrated Food Safety System (U18) Apply for RFA FD 15 039 Funding Number: RFA FD 15 039 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| A Community Research Resource of Microbiome Derived Factors Modulating Host Physiology in Obesity, Digestive and Liver Diseases, and Nutrition (R24) Apply for RFA DK 15 012 Funding Number: RFA DK 15 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Exploratory Studies for Delineating Microbiome Host Interactions in Obesity, Digestive and Liver Diseases and Nutrition (R21) Apply for RFA DK 15 013 Funding Number: RFA DK 15 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Exploration of the Roles of Brown and Beige Adipose Tissue in Humans (R01) Apply for RFA DK 15 031 Funding Number: RFA DK 15 031 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding FDAs Produce Safety and Instructor Skills Training under the Food Safety Modernization Act Apply for RFA FD 15 041 Funding Number: RFA FD 15 041 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Mechanisms Underlying the Contribution of Type 1 Diabetes Risk Associated Variants (DP3) Apply for RFA DK 15 025 Funding Number: RFA DK 15 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Mouse Metabolic Phenotyping Centers Consortium (U2C) Apply for RFA DK 15 010 Funding Number: RFA DK 15 010 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Coordinating and Bioinformatics Unit for the Mouse Metabolic Phenotyping Centers and the Diabetic Complications Consortium (U24) Apply for RFA DK 15 011 Funding Number: RFA DK 15 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $10,100,000 |
| Limited Competition for the Continuation of Teen LABS (Adolescent Longitudinal Assessment of Bariatric Surgery) Clinical Centers (Collaborative U01) Apply for RFA DK 15 508 Funding Number: RFA DK 15 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Teen LABS (Adolescent Longitudinal Assessment of Bariatric Surgery) Biostatistics Research Center (Collaborative U01) Apply for RFA DK 15 509 Funding Number: RFA DK 15 509 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Atlas Projects (U01) Apply for RFA DK 15 014 Funding Number: RFA DK 15 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Database/Website Project (U24) Apply for RFA DK 15 015 Funding Number: RFA DK 15 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Human Tissue Core (U24) Apply for RFA DK 15 016 Funding Number: RFA DK 15 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $400,000 |
| Lymphatics in Health and Disease in the Digestive System, Kidney, and Urinary Tract (R01) Apply for PAR 15 306 Funding Number: PAR 15 306 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Small Business Innovation Research (SBIR) to Develop New or Improved Closed Loop Automated Technologies for Diabetes Therapy and Monitoring (R43/R44) Apply for RFA DK 15 022 Funding Number: RFA DK 15 022 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 15 025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.